Form D · Biotechnology
Northern Mosaic LP
Toronto, A6 · CIK 0001779897
Offering snapshot reported Jun 28, 2019 · SEC filing
- Reported sold
- $7.29M Offering amount: $7.29M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 14, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 28, 2019 | Initial | $7,292,116 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-343083
Source: Form D, filed Jun 28, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bradley Bolzon | Director |
| Jerel Davis | Director |
| Darlene Deptula Hicks | Executive |
| Kelly Honohan | Executive |
| (General Partner Of The Issuer) Northern Biologics Gp Corporation | Executive |
| Joan Seoane Suarez | Director |
| Philip Vickers | Director, Executive |
| Bradly Wouters | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
101 College Street, Pmcrt 15 701
Toronto, A6, M5G 1L7
Toronto, A6, M5G 1L7